Rossby Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.85M Buy
2,376
+749
+46% +$765K 0.52% 36
2026
Q1
$1.55M Buy
1,627
+217
+15% +$220K 0.32% 62
2025
Q4
$1.52M Sell
1,410
-113
-7% -$108K 0.47% 38
2025
Q3
$1.26M Buy
1,523
+285
+23% +$212K 0.41% 42
2025
Q2
$965K Buy
1,238
+324
+35% +$252K 0.36% 50
2025
Q1
$808K Buy
914
+421
+85% +$350K 0.34% 54
2024
Q4
$381K Buy
+493
New +$408K 0.24% 109

Other funds holding LLY

Rossby Financial's LLY Position: Q2 2026 in Review

Rossby Financial increased its Eli Lilly (LLY) stake by 46% in Q2 2026, buying an estimated $765K and bringing the position to 2,376 shares worth $2.85M. The position accounts for 0.52% of the portfolio, ranked #36.

Rossby Financial first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Rossby Financial held 2,376 shares of Eli Lilly worth $2.85M as of Q2 2026.
  • Rossby Financial bought 749 Eli Lilly shares in Q2 2026, an estimated $765K.
  • Eli Lilly made up 0.52% of Rossby Financial's portfolio in Q2 2026, its #36 holding.
  • Rossby Financial first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Rossby Financial's 13F filing for Q2 2026, filed 4 Aug 2026.